Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
D002511:Cephalosporins / Q000378:metabolism* / Q000494:pharmacology; D019818:Clavulanic Acid; D004352:Drug Resistance, Microbial; D004754:Enterobacter / Q000187:drug effects / Q000201:enzymology*; D004755:Enterobacteriaceae / Q000201:enzymology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology*; D012706:Serratia marcescens / Q000187:drug effects / Q000201:enzymology*; D013211:Staphylococcus aureus / Q000187:drug effects; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000378:metabolism; D047090:beta-Lactams / Q000494:pharmacology
D002511:Cephalosporins; D004791:Enzyme Inhibitors; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; D019818:Clavulanic Acid; D001618:beta-Lactamases